Occurrence of Biased mTOR Signaling in Hepatocellular Carcinoma
Rudransh Singh, Niriksha Patel, Neha Singh, Pooja Mourya, Ashish Shingade, Anjali Mange, Jasmine Kaur, Sakshi Beloshe, Ashok Dudhalkar, P. Chavan, Ghanapriya Yengkhom, Shraddha Patkar, Mahesh Goel, Arvind Ingle, Sagar Ranjan Tripathy, , Sunil Shetty
This study identifies biased mTOR signaling in hepatocellular carcinoma (HCC) and shows that dual inhibition of mTORC1 and mTORC2 significantly reduces HCC progression.
bioRxiv · Jul 26, 2026 · PreprintCancer Biology